Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Man Xu

1PUBLICATIONS

15CO-AUTHORS

Molecular targets

Featured researcher

Get your video featured.

Publish with JoVE

Featured researcher

Get your video featured.

Publish with JoVE

Publications (1)

Sort by Publication Date:

|Apr 17, 2024

Overcoming Osimertinib Resistance with AKT Inhibition in EGFRm-Driven Non-Small Cell Lung Cancer with PIK3CA/PTEN Alterations.

Ursula Grazini, Aleksandra Markovets, Lucy Ireland

Pageof 1

Frequent Collaborators

1 joint publications

Ursula Grazini

1 joint publications

Aleksandra Markovets

1 joint publications

Lucy Ireland

1 joint publications

Daniel O'Neill

1 joint publications

Benjamin Phillips

1 joint publications

Matthias Pfeifer

1 joint publications

Tereza Vaclova

1 joint publications

Matthew J Martin

1 joint publications

Ludovic Bigot

1 joint publications

Luc Friboulet

Frequent Collaborators

1 joint publications

Ursula Grazini

1 joint publications

Aleksandra Markovets

1 joint publications

Lucy Ireland

1 joint publications

Daniel O'Neill

Top Related Videos

Establishment and Characterization of Three Afatinib-resistant Lung Adenocarcinoma PC-9 Cell Lines Developed with Increasing Doses of Afatinib

Establishment and Characterization of Three Afatinib-resistant Lung Adenocarcinoma PC-9 Cell Lines Developed with Increasing Doses of Afatinib

Published on : Jun 26, 2019

See more related videos

Top Related Videos

Establishment and Characterization of Three Afatinib-resistant Lung Adenocarcinoma PC-9 Cell Lines Developed with Increasing Doses of Afatinib

Establishment and Characterization of Three Afatinib-resistant Lung Adenocarcinoma PC-9 Cell Lines Developed with Increasing Doses of Afatinib

Published on : Jun 26, 2019

See more related videos